AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 68 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 3.22 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,493,254 | -36.4% | 192,182 | -20.7% | 0.00% | 0.0% |
| Q2 2023 | $2,346,142 | +62.8% | 242,370 | +84.4% | 0.00% | 0.0% |
| Q1 2023 | $1,440,900 | +616.4% | 131,469 | +182.4% | 0.00% | – |
| Q4 2022 | $201,126 | -27.1% | 46,557 | +26.8% | 0.00% | – |
| Q3 2022 | $276,000 | -81.7% | 36,725 | -75.5% | 0.00% | -100.0% |
| Q2 2022 | $1,508,000 | -40.6% | 150,018 | -26.9% | 0.00% | 0.0% |
| Q1 2022 | $2,540,000 | -2.4% | 205,167 | +80.3% | 0.00% | 0.0% |
| Q4 2021 | $2,602,000 | -55.3% | 113,786 | -56.8% | 0.00% | -50.0% |
| Q3 2021 | $5,823,000 | +72.7% | 263,129 | +1.1% | 0.00% | +100.0% |
| Q2 2021 | $3,372,000 | +1.9% | 260,205 | +2.1% | 0.00% | 0.0% |
| Q1 2021 | $3,309,000 | +10.7% | 254,832 | +17.9% | 0.00% | 0.0% |
| Q4 2020 | $2,988,000 | +19.8% | 216,083 | +27.6% | 0.00% | 0.0% |
| Q3 2020 | $2,494,000 | +50.8% | 169,316 | +66.4% | 0.00% | 0.0% |
| Q2 2020 | $1,654,000 | -6.9% | 101,782 | -16.8% | 0.00% | 0.0% |
| Q1 2020 | $1,776,000 | +5.7% | 122,402 | +47.5% | 0.00% | 0.0% |
| Q4 2019 | $1,681,000 | +4323.7% | 82,960 | +1076.1% | 0.00% | – |
| Q3 2019 | $38,000 | -9.5% | 7,054 | +9.5% | 0.00% | – |
| Q2 2019 | $42,000 | -8.7% | 6,443 | -8.3% | 0.00% | – |
| Q1 2019 | $46,000 | -16.4% | 7,024 | -14.2% | 0.00% | – |
| Q4 2018 | $55,000 | -93.6% | 8,182 | -93.7% | 0.00% | – |
| Q3 2018 | $857,000 | +26.4% | 128,970 | +7.1% | 0.00% | – |
| Q2 2018 | $678,000 | +13.2% | 120,435 | +4.3% | 0.00% | – |
| Q1 2018 | $599,000 | +11.3% | 115,435 | -2.9% | 0.00% | – |
| Q4 2017 | $538,000 | -7.6% | 118,835 | +28.0% | 0.00% | – |
| Q3 2017 | $582,000 | -3.6% | 92,835 | -5.8% | 0.00% | – |
| Q2 2017 | $604,000 | -26.7% | 98,540 | -12.3% | 0.00% | – |
| Q1 2017 | $824,000 | +296.2% | 112,314 | +13.6% | 0.00% | – |
| Q4 2016 | $208,000 | -0.5% | 98,909 | +42.6% | 0.00% | – |
| Q3 2016 | $209,000 | +3383.3% | 69,360 | +3335.4% | 0.00% | – |
| Q1 2016 | $6,000 | -85.7% | 2,019 | -88.1% | 0.00% | – |
| Q4 2015 | $42,000 | – | 16,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |